US regulators to examine testosterone therapy as use by menopausal women rises - Reuters
US regulators to examine testosterone therapy as use by menopausal women rises Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
Tags
All Coverage
<a href="https://news.google.com/rss/articles/CBMi3AFBVV95cUxNSHlJU2cxWUJOSnBoMVZZMHBhSW94RWlkU2ZUM0pPSXJ0ZGZPOTZmUm52UkNXRzZSLUJHVHNLTm05WmQzdnZ2V3JpUUp2VGhEX2U3Mm5NODJXLTk2b3EyVVQxb3dodGM1dEowNUhKUWYxbGxZSTJIMWhCOHFIdVU4MVZUdG9lYmVMa3JIcmJ0TTcyQWJONWo0Z0E5ZlA0Nkp0V1ptNVFyY2htTHFQR0dIdVM3enp1OVQ1UHhXNzZEUG0tMjVQTkxJc1BOSXg1RFU2Y0NxbDlfeTlwV1JK?oc=5" target="_blank">US regulators to examine testosterone therapy as use by menopausal women rises</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
US FDA advisers endorse Grail cancer test's benefits in key vote - Reuters
US FDA advisers endorse Grail cancer test's benefits in key vote Reuters
September 23, 2026 at 11:03 PMInvitation for men to 'experience hot flushes'
A MenoVest will allow people at an event in Hull to experience one of the symptoms of the menopause.
September 21, 2026 at 05:07 PMWegovy-maker Novo faces calls to map out strategy beyond weight-loss drugs - reuters.com
Wegovy-maker Novo faces calls to map out strategy beyond weight-loss drugs reuters.com
September 21, 2026 at 05:02 AMUS FDA approves AbbVie's drug for Parkinson's disease - reuters.com
US FDA approves AbbVie's drug for Parkinson's disease reuters.com
September 25, 2026 at 10:57 PMTrump's FDA pick to face vaccine, abortion pill questions at US Senate hearing - Reuters
Trump's FDA pick to face vaccine, abortion pill questions at US Senate hearing Reuters
September 24, 2026 at 10:24 AMUS FDA approves Mirum's drug for rare bone disorder - reuters.com
US FDA approves Mirum's drug for rare bone disorder reuters.com
September 25, 2026 at 08:11 PM